1. Glucagon-like peptide 1 receptor agonist liraglutide impacts immune cell phenotypes in apolipoprotein e deficient mice during progression and regression of pre-established atherosclerosis. (August 2018) Authors: Bruen, R.; Curley, S.; Kajani, S.; O'reilly, M.; Hogan, A.; O'shea, D.; Mcgillicuddy, F.; Belton, O. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of Early Integration of Palliative Care on Health Care Proxy (HCP) Documentation by Patients with Myelodysplastic Syndromes (MDS). (April 2017) Authors: Desai, A.V.; Chow, K.; Wan, P.J.; O'shea, D.; Ranaghan, C.; Anderson, K.; Kramer, D.; Goldberg, J.I.; Rawlins, R.; Koczela, E.; Klimek, V.M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Symptom Burden of Patients with Newly Diagnosed Myelodysplastic Syndromes (MDS) Receiving Outpatient Cancer Care. (April 2017) Authors: Desai, A.V.; Goldberg, J.I.; Anderson, K.; Ranaghan, C.; O'shea, D.; Chow, K.; Kramer, D.; Rawlins, R.; Wan, P.J.; Klimek, V.M.; Nelson, J.E. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗